The Montreal Heart Institute (MHI) announces that the BRAIN-AF study has received a $1.4 million grant from the Canadian Institutes of Health Research. Seeking to better understand the effects of cardiovascular disease on the cognitive decline of the brain, the study will be able to recruit participants remotely thanks to this funding.

A natural product to fight symptoms related to COVID-19

The Montreal Heart Institute (MHI) is launching a new clinical trial to evaluate the effect of hesperidin on symptoms related to COVID-19. This flavonoid naturally found in citrus fruits has distinct properties that may reduce the entry and replication of the SARS-CoV2 virus in the body along with the modulation of inflammatory mediators, thus potentially reducing symptoms and prevent complications from the disease.

Due to an outbreak in the surgical continuum, caregiver visits are suspended indefinitely.

Caregivers will not be able to come to the surgical intensive care unit (3rd east) and the surgical unit (3rd center) until further notice.

In exceptional situations or for humanitarian reasons (eg: end of life), a caregiver may be authorized, with the agreement of the care unit.